Literature DB >> 1329916

The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus.

C Watala1, H Witas, L Olszowska, W Piasecki.   

Abstract

The association of intracellular viscosity of red blood cells and the dynamic properties of erythrocyte membranes in children suffering from diabetes has been investigated by means of ESR spectroscopy. It has been revealed that the slight decrease in the ratio hw/hs of maleimide bound to membrane protein-SH groups of erythrocytes in diabetes may ensue from the enhanced membrane protein immobilization in the plane of lipid bilayer. These alterations were accompanied by a corresponding increase in the relative rotational correlation time (tau c) of iodoacetamide spin label, thus suggesting that the conformational changes in membrane proteins may occur at both the intrinsic and more exposed thiol groups. The membranes of diabetic red blood cells were more glycosylated than those of relevant controls, and the extent of glycosylation was found to correlate significantly with h + 1/h0 and tau c (r = -0.652, P < 0.01 and r = 0.609, P < 0.01). Further, the conformational alterations in erythrocyte membranes from diabetic subjects were accompanied by a significant increase in the mobility parameter (h + 1/h0) of haemoglobin molecules in diabetic erythrocytes. The latter changes correlated well with the enhanced intracellular viscosity of diabetic red blood cells and the level of glycosylated haemoglobin. We conclude that the alterations in membrane lipid-protein interactions together with the increased glycosylation-derived internal viscosity may consequently imply altered viscoelastic properties of erythrocyte membranes and, underlying the impaired deformability of red blood cells in the diabetic state, contribute to the development of late diabetic sequelae.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329916      PMCID: PMC2002015     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  35 in total

Review 1.  The biochemistry of the complications of diabetes mellitus.

Authors:  M Brownlee; A Cerami
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 2.  Protein modification by non-enzymatic glucosylation: possible role in the development of diabetic complications.

Authors:  O H Wieland
Journal:  Mol Cell Endocrinol       Date:  1983-02       Impact factor: 4.102

3.  Measurement of nonenzymatic protein glycosylation.

Authors:  R Flückiger; P M Gallop
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

Review 4.  The spin-label approach to labeling membrane protein sulfhydryl groups.

Authors:  L J Berliner
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

5.  Affinity of hemoglobin for the cytoplasmic fragment of human erythrocyte membrane band 3. Equilibrium measurements at physiological pH using matrix-bound proteins: the effects of ionic strength, deoxygenation and of 2,3-diphosphoglycerate.

Authors:  G Chétrite; R Cassoly
Journal:  J Mol Biol       Date:  1985-10-05       Impact factor: 5.469

Review 6.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

7.  Glycosylated haemoglobins and the oxygen affinity of whole blood.

Authors:  M Samaja; D Melotti; A Carenini; G Pozza
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

8.  Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity.

Authors:  J L Witztum; E M Mahoney; M J Branks; M Fisher; R Elam; D Steinberg
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

9.  The localization of Mg-Na-K-activated adenosine triphosphatase on red cell ghost membranes.

Authors:  V T Marchesi; G E Palade
Journal:  J Cell Biol       Date:  1967-11       Impact factor: 10.539

10.  Is hyperviscosity a treatable component of diabetic microcirculatory disease?

Authors:  A J Barnes; P Locke; P R Scudder; T L Dormandy; J A Dormandy; J Slack
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

View more
  7 in total

Review 1.  Biomechanical properties of red blood cells in health and disease towards microfluidics.

Authors:  Giovanna Tomaiuolo
Journal:  Biomicrofluidics       Date:  2014-09-17       Impact factor: 2.800

2.  Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors?

Authors:  Jumana Saleh
Journal:  World J Cardiol       Date:  2015-08-26

3.  HEMOGLOBIN A1c LEVEL HIGHER THAN 9.05% CAUSES A SIGNIFICANT IMPAIRMENT OF ERYTHROCYTE DEFORMABILITY IN DIABETES MELLITUS.

Authors:  Q Li; L Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

4.  Structural alterations of the erythrocyte membrane proteins in diabetic retinopathy.

Authors:  Ioannis K Petropoulos; Panagiotis I Margetis; Marianna H Antonelou; John X Koliopoulos; Sotirios P Gartaganis; Lukas H Margaritis; Issidora S Papassideri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

Review 5.  Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients.

Authors:  Shariq I Sherwani; Haseeb A Khan; Aishah Ekhzaimy; Afshan Masood; Meena K Sakharkar
Journal:  Biomark Insights       Date:  2016-07-03

Review 6.  Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes.

Authors:  Hoyoon Lee; Wonwhi Na; Sang Bae Lee; Chul Woo Ahn; Jun Sung Moon; Kyu Chang Won; Sehyun Shin
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

7.  Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients.

Authors:  Pedro Cabrales; Miguel A Salazar Vázquez; Beatrizy Salazar Vázquez; Martha Rodríguez-Morán; Marcos Intaglietta; Fernando Guerrero-Romeros
Journal:  Vasc Health Risk Manag       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.